Anjali D Deshpande1, Marcie Harris-Hayes, Mario Schootman. 1. Division of Health Behavior Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. deshpaad@gmail.com
Abstract
UNLABELLED: In 2005, it was estimated that more than 20 million people in the United States had diabetes. Approximately 30% of these people had undiagnosed cases. Increased risk for diabetes is primarily associated with age, ethnicity, family history of diabetes, smoking, obesity, and physical inactivity. Diabetes-related complications--including cardiovascular disease, kidney disease, neuropathy, blindness, and lower-extremity amputation--are a significant cause of increased morbidity and mortality among people with diabetes, and result in a heavy economic burden on the US health care system. With advances in treatment for diabetes and its associated complications, people with diabetes are living longer with their condition. This longer life span will contribute to further increases in the morbidity associated with diabetes, primarily in elderly people and in minority racial or ethnic groups. In 2050, the number of people in the United States with diagnosed diabetes is estimated to grow to 48.3 million. RESULTS: from randomized controlled trials provide evidence that intensive lifestyle interventions can prevent or delay the onset of diabetes in high-risk individuals. In addition, adequate and sustained control of blood sugar levels, blood pressure, and blood lipid levels can prevent or delay the onset of diabetes-related complications in people with diabetes. Effective interventions, at both the individual and population levels, are desperately needed to slow the diabetes epidemic and reduce diabetes-related complications in the United States. This report describes the current diabetes epidemic and the health and economic impact of diabetes complications on individuals and on the health care system. The report also provides suggestions by which the epidemic can be curbed.
UNLABELLED: In 2005, it was estimated that more than 20 million people in the United States had diabetes. Approximately 30% of these people had undiagnosed cases. Increased risk for diabetes is primarily associated with age, ethnicity, family history of diabetes, smoking, obesity, and physical inactivity. Diabetes-related complications--including cardiovascular disease, kidney disease, neuropathy, blindness, and lower-extremity amputation--are a significant cause of increased morbidity and mortality among people with diabetes, and result in a heavy economic burden on the US health care system. With advances in treatment for diabetes and its associated complications, people with diabetes are living longer with their condition. This longer life span will contribute to further increases in the morbidity associated with diabetes, primarily in elderly people and in minority racial or ethnic groups. In 2050, the number of people in the United States with diagnosed diabetes is estimated to grow to 48.3 million. RESULTS: from randomized controlled trials provide evidence that intensive lifestyle interventions can prevent or delay the onset of diabetes in high-risk individuals. In addition, adequate and sustained control of blood sugar levels, blood pressure, and blood lipid levels can prevent or delay the onset of diabetes-related complications in people with diabetes. Effective interventions, at both the individual and population levels, are desperately needed to slow the diabetes epidemic and reduce diabetes-related complications in the United States. This report describes the current diabetes epidemic and the health and economic impact of diabetes complications on individuals and on the health care system. The report also provides suggestions by which the epidemic can be curbed.
Authors: J Michael Underwood; Julie S Townsend; Sherri L Stewart; Natasha Buchannan; Donatus U Ekwueme; Nikki A Hawkins; Jun Li; Brandy Peaker; Lori A Pollack; Thomas B Richards; Sun Hee Rim; Elizabeth A Rohan; Susan A Sabatino; Judith L Smith; Eric Tai; George-Ann Townsend; Arica White; Temeika L Fairley Journal: MMWR Surveill Summ Date: 2012-01-20
Authors: Sean D Candrilli; Keith L Davis; Hong J Kan; Melanie A Lucero; Matthew D Rousculp Journal: J Diabetes Complications Date: 2007 Sep-Oct Impact factor: 2.852
Authors: Michael Brandle; Honghong Zhou; Barbara R K Smith; Deanna Marriott; Ray Burke; Bahman P Tabaei; Morton B Brown; William H Herman Journal: Diabetes Care Date: 2003-08 Impact factor: 19.112
Authors: Mario Schootman; Elena M Andresen; Fredric D Wolinsky; Theodore K Malmstrom; J Philip Miller; Yan Yan; Douglas K Miller Journal: Am J Epidemiol Date: 2007-07-11 Impact factor: 4.897
Authors: J Frank Wharam; Christine Y Lu; Fang Zhang; Matthew Callahan; Xin Xu; Jamie Wallace; Stephen Soumerai; Dennis Ross-Degnan; Joseph P Newhouse Journal: Ann Intern Med Date: 2018-11-20 Impact factor: 25.391